James Richard Duncan

James Richard Duncan, MD, PhD

  • Radiology

Sees Patients For

Vascular interventional radiology, improving quality and safety

Patients Seen At

Hospital Affiliations

  • Barnes-Jewish Hospital
  • Barnes-Jewish St. Peters Hospital
  • St. Louis Children's Hospital

Board Certifications

  • Vascular and Interventional Radiology
  • Diagnostic Radiology

Academic Title(s)

Professor, Radiology
Chief, Division of Interventional Radiology


  • English



1997 Vascular & Interventional Radiology, Mallinckrodt Institute of Radiology, St. Louis, Missouri


1994 Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri


1988 Molecular Biology, Washington University, St. Louis, Missouri

Medical Degree

1988 Washington University School of Medicine, St. Louis, Missouri


1982 University of Michigan, Ann Arbor, Michigan

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

Company Name: Proteon TherapeuticsRoyalties: $1 - $9,999Equity: YesConsulting/Advisory Board: $1 - $9,999Speaker Fees: $1 - $9,999Reporting Date: 05/01/2020